CoChat

Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes

Open access
Argyropoulos, Christos, Wang, Kai, McClarty, Sara, Huang, David, Bernardo, Jose, Ellis, Demetrius, Orchard, Trevor, Galas, David, Johnson, John · 2013 · PLoS ONE
Cited by 157

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better understanding of the factors affecting kidney disease progression in T1D is urgently needed. In recent years microRNAs have emerged as important post-transcriptional regulators of gene expression in many different health conditions. We hypothesized that urinary microRNA profile of patients will differ in the different stages of diabetic renal disease. METHODS AND FINDINGS: We studied urine microRNA profiles with qPCR in 40 T1D with >20 year follow up 10 who never developed renal disease (N) matched against 10 patients who went on to develop overt nephropathy (DN), 10 patients with intermittent microalbuminuria (IMA) matched against 10 patients with persistent (PMA) microalbuminuria. A Bayesian procedure was used to normalize and convert raw signals to expression ratios. We applied formal statistical techniques to translate fold changes to profiles of microRNA targets which were then used to make inferences about biological pathways in the Gene Ontology and REACTOME structured vocabularies. A total of 27 microRNAs were found to be present at significantly different levels in different stages of untreated nephropathy. These microRNAs mapped to overlapping pathways pertaining to growth factor signaling and renal fibrosis known to be targeted in diabetic kidney disease. CONCLUSIONS: Urinary microRNA profiles differ across the different stages of diabetic nephropathy. Previous work using experimental, clinical chemistry or biopsy samples has demonstrated differential expression of many of these microRNAs in a variety of chronic renal conditions and diabetes. Combining expression ratios of microRNAs with formal inferences about their predicted mRNA targets and associated biological pathways may yield useful markers for early diagnosis and risk stratification of DN in T1D by inferring the alteration of renal molecular processes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0054662

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 55

  1. ME Molitch, 2004, Nephropathy in diabetes, Diabetes Care, 27, S79, 10.2337/diacare.27.2007.S79 · DOI · Paper page
  2. YS Kanwar, 2011, A glimpse of various pathogenetic mechanisms of diabetic nephropathy, Annu Rev Pathol, 6, 395, 10.1146/annurev.pathol.4.110807.092150 · DOI · Paper page
  3. RW Carthew, 2009, Origins and Mechanisms of miRNAs and siRNAs, Cell, 136, 642, 10.1016/j.cell.2009.01.035 · DOI · Paper page
  4. RC Lee, 2001, An extensive class of small RNAs in Caenorhabditis elegans, Science, 294, 862, 10.1126/science.1065329 · DOI · Paper page
  5. DP Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  6. P Kantharidis, 2011, Diabetes complications: the microRNA perspective, Diabetes, 60, 1832, 10.2337/db11-0082 · DOI · Paper page
  7. K Bhatt, 2011, microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles, Am J Physiol Renal Physiol, 300, F602, 10.1152/ajprenal.00727.2010 · DOI · Paper page
  8. M Kato, 2009, MicroRNAs and their role in progressive kidney diseases, Clin J Am Soc Nephrol, 4, 1255, 10.2215/CJN.00520109 · DOI · Paper page
  9. JM Lorenzen, 2011, MicroRNAs as mediators and therapeutic targets in chronic kidney disease, Nat Rev Nephrol, 7, 286, 10.1038/nrneph.2011.26 · DOI · Paper page
  10. T Roweis, Sam, 1998, EM Algororithms for PCA and SPCA. Advances in Neural Information Processing Systems. Colorado, USA, 1997: The MIT Press, Vol, 10, 626
  11. W Stacklies, 2007, pcaMethods–a bioconductor package providing PCA methods for incomplete data, Bioinformatics, 23, 1164, 10.1093/bioinformatics/btm069 · DOI · Paper page
  12. RC Gentleman, 2004, Bioconductor: open software development for computational biology and bioinformatics, Genome Biol, 5, R80, 10.1186/gb-2004-5-10-r80 · DOI · Paper page
  13. MW Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, e45, 10.1093/nar/29.9.e45 · DOI · Paper page
  14. Box GEP, Tiao GC (1973) Nature Of Bayesian Inference. Bayesian Inference In Statistical Analysis. Wiley Classics Library. 1–75.
  15. L Held, 2004, Simultaneous Posterior Probability Statements from Monte Carlo Output, Journal of Computational and Graphical Statistics, 13, 20, 10.1198/1061860043083 · DOI
  16. X Wang, 2008, Prediction of both conserved and nonconserved microRNA targets in animals, Bioinformatics, 24, 325, 10.1093/bioinformatics/btm595 · DOI · Paper page
  17. M Ashburner, 2000, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet, 25, 25, 10.1038/75556 · DOI · Paper page
  18. G Wang, 2010, Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis, Am J Hypertens, 23, 78, 10.1038/ajh.2009.208 · DOI
  19. L Denby, 2011, miR-21 and miR-214 are consistently modulated during renal injury in rodent models, Am J Pathol, 179, 661, 10.1016/j.ajpath.2011.04.021 · DOI
  20. X-Y Bai, 2011, miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes, J Am Soc Nephrol, 22, 1252, 10.1681/ASN.2010040367 · DOI · Paper page
  21. G Wang, 2011, Serum and urinary free microRNA level in patients with systemic lupus erythematosus, Lupus, 20, 493, 10.1177/0961203310389841 · DOI · Paper page
  22. Y Dai, 2009, Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients, Rheumatol Int, 29, 749, 10.1007/s00296-008-0758-6 · DOI · Paper page
  23. G Wang, 2010, Expression of microRNAs in the urinary sediment of patients with IgA nephropathy, Dis Markers, 28, 79, 10.1155/2010/396328 · DOI · Paper page
  24. Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, <etal>et al</etal>.. (2011) Urinary miR-210 as a Mediator of Acute T-Cell Mediated Rejection in Renal Allograft Recipients. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Available:http://www.ncbi.nlm.nih.gov/pubmed/21812927. Accessed 25 September 2011. · DOI · Paper page
  25. AO Phillips, 1997, Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation, Kidney Int, 52, 973, 10.1038/ki.1997.419 · DOI
  26. SW Shan, 2009, MicroRNA MiR-17 retards tissue growth and represses fibronectin expression, Nat Cell Biol, 11, 1031, 10.1038/ncb1917 · DOI · Paper page
  27. M Hackl, 2010, miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging, Aging Cell, 9, 291, 10.1111/j.1474-9726.2010.00549.x · DOI · Paper page
  28. H Sun, 2010, MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation, Mol Biol Rep, 37, 2951, 10.1007/s11033-009-9861-3 · DOI
  29. U Tran, 2010, The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity, Development, 137, 1107, 10.1242/dev.046045 · DOI · Paper page
  30. J Hou, 2007, Transgenic RNAi Depletion of Claudin-16 and the Renal Handling of Magnesium, Journal of Biological Chemistry, 282, 17114, 10.1074/jbc.M700632200 · DOI · Paper page
  31. L Mahimainathan, 2006, Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN, Diabetes, 55, 2115, 10.2337/db05-1326 · DOI · Paper page
  32. Z Chun-Zhi, 2010, MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN, BMC Cancer, 10, 367, 10.1186/1471-2407-10-367 · DOI · Paper page
  33. S Fatima, 2012, Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model, Stem Cells, 30, 210, 10.1002/stem.1002 · DOI
  34. R Liao, 2008, MicroRNAs play a role in the development of human hematopoietic stem cells, J Cell Biochem, 104, 805, 10.1002/jcb.21668 · DOI · Paper page
  35. VA Valera, 2011, Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma, J Cancer, 2, 515, 10.7150/jca.2.515 · DOI
  36. P Dentelli, 2010, microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression, Arterioscler Thromb Vasc Biol, 30, 1562, 10.1161/ATVBAHA.110.206201 · DOI · Paper page
  37. G Togliatto, 2011, MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage, Diabetologia, 54, 1930, 10.1007/s00125-011-2125-5 · DOI
  38. G Ghosh, 2010, Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis, J Clin Invest, 120, 4141, 10.1172/JCI42980 · DOI · Paper page
  39. Chamorro-Jorganes A, Araldi E, Penalva LOF, Sandhu D, Fernández-Hernando C, <etal>et al</etal>.. (2011) MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1. Arteriosclerosis, Thrombosis, and Vascular Biology. Available:http://www.ncbi.nlm.nih.gov/pubmed/21885851. Accessed 25 September 2011. · DOI · Paper page
  40. M Kato, 2007, MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors, Proc Natl Acad Sci USA, 104, 3432, 10.1073/pnas.0611192104 · DOI · Paper page
  41. M Kato, 2011, A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells, Kidney Int, 80, 358, 10.1038/ki.2011.43 · DOI · Paper page
  42. A Krupa, 2010, Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy, Journal of the American Society of Nephrology, 21, 438, 10.1681/ASN.2009050530 · DOI · Paper page
  43. D Macconi, 2012, MicroRNA-324-3p Promotes Renal Fibrosis and Is a Target of ACE Inhibition, JASN, 23, 1496, 10.1681/ASN.2011121144 · DOI
  44. O García-Sánchez, 2010, An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease, Kidney Int, 77, 950, 10.1038/ki.2010.88 · DOI
  45. Ostendorf T, Eitner F, Floege J (2011) The PDGF family in renal fibrosis. Pediatr Nephrol. Available:http://www.ncbi.nlm.nih.gov/pubmed/21597969. Accessed 4 September 2011.
  46. SM Titan, 2011, FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy, Clinical Journal of the American Society of Nephrology, 6, 241, 10.2215/CJN.04250510 · DOI
  47. K Heese, 2003, Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells, Biochem Pharmacol, 65, 293, 10.1016/S0006-2952(02)01487-9 · doi:10.1016/s0006-2952(02)01487-9
  48. A Micera, 2001, Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair, Proc Natl Acad Sci USA, 98, 6162, 10.1073/pnas.101130898 · DOI · Paper page
  49. R Bonofiglio, 2007, Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys, J Nephrol, 20, 186
  50. D Shan, 2012, Pentoxifylline for diabetic kidney disease, Cochrane Database Syst Rev, 2, CD006800
  51. K Sharma, 2011, Pirfenidone for diabetic nephropathy, J Am Soc Nephrol, 22, 1144, 10.1681/ASN.2010101049 · DOI · Paper page
  52. P Ruggenenti, 2004, Preventing microalbuminuria in type 2 diabetes, N Engl J Med, 351, 1941, 10.1056/NEJMoa042167 · DOI · Paper page
  53. Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, <etal>et al</etal>.. (2011) MicroRNA Profiles in Allograft Tissues and Paired Urines Associate With Chronic Allograft Dysfunction With IF/TA. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Available:http://www.ncbi.nlm.nih.gov/pubmed/21794090. Accessed 25 September 2011. · DOI · Paper page
  54. Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JYZ, <etal>et al</etal>.. (2011) Circulating microRNA expression is reduced in chronic kidney disease. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association. Available:http://www.ncbi.nlm.nih.gov/pubmed/21891774. Accessed 25 September 2011. · DOI · Paper page
  55. JA Weber, 2010, The microRNA spectrum in 12 body fluids, Clin Chem, 56, 1733, 10.1373/clinchem.2010.147405 · DOI · Paper page

Cited by

See all 157

Metadata

Authors
Argyropoulos, C., Wang, K., McClarty, S., Huang, D., Bernardo, J., Ellis, D., Orchard, T., Galas, D., & Johnson, J.
Venue
PLoS ONE
Published
2013-01-24
Volume
8
Issue
1
Pages
e54662
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1967550939
Cited by
157
References
8
FWCI
18.34
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes. https://app.cochat.ai/papers/10.1371/journal.pone.0054662
The paper
Argyropoulos, C., Wang, K., McClarty, S., Huang, D., Bernardo, J., Ellis, D., Orchard, T., Galas, D., & Johnson, J. (2013). Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes. PLoS ONE. https://doi.org/10.1371/journal.pone.0054662

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.